Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-004177
Filing Date
2023-02-21
Accepted
2023-02-21 09:42:23
Documents
2
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 6-K firstpatientenrolledinpedi.htm 6-K 45836
2 GRAPHIC logo_greyxoriginalx.jpg GRAPHIC 115057
  Complete submission text file 0001628280-23-004177.txt   192948
Mailing Address DARWINWEG 24 LEIDEN P7 2333 CR
Business Address DARWINWEG 24 LEIDEN P7 2333 CR 31 (0)71 5247 400
Pharming Group N.V. (Filer) CIK: 0001828316 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39822 | Film No.: 23645683
SIC: 2834 Pharmaceutical Preparations